1U.K.The following substances and products, namely:—
[F1(a)]
Acetorphine.
[F2Alfentanil.]
Allylprodine.
Alphacetylmethadol.
Alphameprodine.
Alphamethadol.
Alphaprodine.
Anileridine.
Benzethidine.
Benzylmorphine (3-benzylmorphine).
Betacetylmethadol.
Betameprodine.
Betamethadol.
Betaprodine.
Bezitramide.
Bufotenine.
F3...
F4...
[F5Carfentanil.]
Clonitazene.
Coca leaf.
Cocaine.
Desomorphine.
Dextromoramide.
Diamorphine.
Diampromide.
Diethylthiambutene.
[F6Difenoxin (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid).]
DihydrocodeinoneO-carboxymethyloxime.
[F7Dihydroetorphine]
Dimenoxadole.
Dimepheptanol.
Dimethylthiambutene.
Dioxaphetyl butyrate.
Diphenoxylate.
Dipipanone.
[F8Drotebanol (3,4-dimethoxy-17-methylmorphinan-6b, 14-diol).]
Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine.
Ethylmethylthiambutene.
[F2Eticyclidine.]
Etonitazene.
Etorphine.
Etoxeridine.
[F9Etryptamine]
Fentanyl.
[F10Fungus (of any kind) which contains psilocin or an ester of psilocin.]
Furethidine.
Hydrocodone.
Hydromorphinol.
Hydromorphone.
Hydroxypethidine.
Isomethadone.
Ketobemidone.
Levomethorphan.
Levomoramide.
Levophenacylmorphan.
Levorphanol.
[F5Lofentanil]
Lysergamide.
Lysergide and otherN-alkyl derivatives of lysergamide.
Mescaline.
Metazocine.
Methadone.
Methadyl acetate.
[F11Methylamphetamine]
Methyldesorphine.
Methyldihydromorphine (6-methyldihydromorphine).
Metopon.
Morpheridine.
Morphine.
Morphine methobromide, morphineN-oxide and other pentavalent nitrogen morphine derivatives.
Myrophine.
F12. . .
Nicomorphine (3,6-dinicotinoylmorphine).
Noracymethadol.
Norlevorphanol.
Normethadone.
Normorphine.
Norpipanone.
Opium, whether raw, prepared or medicinal.
Oxycodone.
Oxymorphone.
Pethidine.
Phenadoxone.
Phenampromide.
Phenazocine.
[F13Phencyclidine.]
Phenomorphan.
Phenoperidine.
Piminodine.
Piritramide.
Poppy-straw and concentrate of poppy-straw.
Proheptazine.
Properidine (1-methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester).
Psilocin.
Racemethorphan.
Racemoramide.
Racemorphan.
[F14Remifentanil]
[F2Rolicyclidine.]
[F15Sufentanil.]
[F2Tenocylidine.]
Thebacon.
Thebaine.
[F15Tilidate.]
Trimeperidine.
[F164-Bromo-2,5-dimethoxy-a-methylphenethylamine].
4-Cyano-2-dimethylamino-4,4-diphenylbutane.
4-Cyano-1-methyl-4-phenyl-piperidine.
N,N-Diethyltryptamine.
N,N-Dimethyltryptamine.
2,5-Dimethoxy-a,4-dimethylphenethylamine.
[F17N-Hydroxy-tenamphetamine.]
1-Methyl-4-phenylpiperidine-4-carboxylic acid.
2-Methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid.
[F184-Methyl-aminorex]
4-Phenylpiperidine-4-carboxylic acid ethyl ester.
[F19(b)any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;
[F20(ba)the following phenethylamine derivatives, namely:—
Allyl( a -methyl-3,4-methylenedioxyphenethyl)amine
2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol
2-Amino-1-(3,4-dimethoxyphenyl)ethanol
Benzyl( a -methyl-3,4-methylenedioxyphenethyl)amine
4-Bromo- b ,2,5-trimethoxyphenethylamine
N -(4- sec -Butylthio-2,5-dimethoxyphenethyl)hydroxylamine
Cyclopropylmethyl( a -methyl-3,4-methylenedioxyphenethyl)amine
2-(4,7-Dimethoxy-2,3-dihydro-1 H -indan-5-yl)ethylamine
2-(4,7-Dimethoxy-2,3-dihydro-1 H -indan-5-yl)-1-methylethylamine
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine
2-(1,4-Dimethoxy-2-naphthyl)ethylamine
2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine
N -(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine
2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine
2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine
a , a -Dimethyl-3,4-methylenedioxyphenethylamine
a , a -Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine
Dimethyl( a -methyl-3,4-methylenedioxyphenethyl)amine
N -(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine
4-Iodo-2,5-dimethoxy- a -methylphenethyl(dimethyl)amine
2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine
2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine
2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[ b ]furan-6-yl)-1-methylethylamine
2-Methoxyethyl( a -methyl-3,4-methylenedioxyphenethyl)amine
2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[ b ]furan-6-yl)-1-methylethylamine
b -Methoxy-3,4-methylenedioxyphenethylamine
1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine
1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine
2-( a -Methyl-3,4-methylenedioxyphenethylamino)ethanol
a -Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine
N -Methyl- N -( a -methyl-3,4-methylenedioxyphenethyl)hydroxylamine
O -Methyl- N -( a -methyl-3,4-methylenedioxyphenethyl)hydroxylamine
a -Methyl-4-(methylthio)phenethylamine
b ,3,4,5-Tetramethoxyphenethylamine
b ,2,5-Trimethoxy-4-methylphenethylamine; ]
(c) any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine an N -alkylphenethylamine,a-methylphenethylamine, an N -alkyl-a-methylphenethylamine,a-ethylphenethylamine, or an N -alkyl-a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents. ]
[F21(d)any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say,
(i)by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;
(ii)by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;
(iii)by substitution in the piperidine ring with alkyl or alkenyl groups;
(iv)by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;
(v)by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;
(vi)by replacement of the N-propionyl group by another acyl group;
(e)any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say,
(i)by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;
(ii)by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;
(iii)by substitution in the 4-phenyl ring wiith alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;
(iv)by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;
(v)by formation of an N-oxide or of a quaternary base.]
Textual Amendments
F1"(a)" inserted by S.I. 1977/1243, art. 3(a)
F2Word inserted by S.I. 1984/859, art. 2(2)
F3Words in Sch. 2 Pt. 1 para. 1(a) deleted (29.1.2004) by The Misuse of Drugs Act 1971 (Modification) (No. 2) Order 2003 (S.I. 2003/3201), art. 2(2)
F4Words in Sch. 2 Pt. 1 para. 1(a) deleted (29.1.2004) by The Misuse of Drugs Act 1971 (Modification) (No. 2) Order 2003 (S.I. 2003/3201), art. 2(2)
F5Word inserted by S.I. 1986/2230, art. 2(2)(a)
F6Word inserted by S.I. 1975/421, art. 3
F7Word in Sch. 2 Pt. 1 para. 1(a) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003 /1243), art. 2(2)(a)
F8Word inserted by S.I. 1973/771, art. 2
F9Word in Sch. 2 Pt. I para. 1(a) inserted (1.5.1998) by S.I. 1998/750, art. 2(2)
F10Words in Sch. 2 Pt. 1 para. 1 inserted (18.7.2005) by Drugs Act 2005 (c. 17), s. 21
F11Word in Sch. 2 Pt. 1 para. 1(a) inserted (18.1.2007) by The Misuse of Drugs Act 1971 (Amendment) Order 2006 (S.I. 2006/3331), art. 2(1)
F12Words repealed by S.I. 1973/771, art. 2
F13Word inserted by S.I. 1979/299, art. 2
F14Word in Sch. 2 Pt. 1 para. 1(a) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003 /1243), art. 2(2)(b)
F15Word inserted by S.I. 1983/765, art. 2(a)
F16Words inserted by S.I. 1975/421, art. 3
F17Word inserted by S.I. 1990/2589, art. 2(a)(i)
F18Word inserted by S.I. 1990/2589, art. 2(a)(ii)
F19Sch. 2 Pt. I para. 1(b)(c) added by S.I. 1977/1243, art. 3(b)
F20Sch. 2 Pt. I para. 1(ba) inserted (1.2.2002) by The Misuse of Drugs Act 1971 (Modification) Order 2001 (S.I. 2001/3932), art. 2(2)
F21Sch. 2 Pt. I para. 1(d)(e) added by S.I. 1986/2230, art. 2(2)(b)
2U.K.Any stereoisomeric form of a substance for the time being specified in paragraph 1 above not being dextromethorphan or dextrorphan.
3U.K.Any ester or ether of a substance for the time being specified in paragraph 1 or 2 above [F22not being a substance for the time being specified in Part II of this Schedule].
Textual Amendments
F22Words inserted by S.I. 1973/771, art. 2
4U.K.Any salt of a substance for the time being specified in any of paragraphs 1 to 3 above.
5U.K.Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 4 above.
6U.K.Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1 to 3 of Part II of this Schedule.